Changeflow GovPing Search

1 result for "PHI THERAPEUTICS, INC."

• USPTO Patent Grants - Pharma (A61K)
Favicon for changeflow.com

PHI Therapeutics Bacteriophage Eczema Patent Granted

The USPTO granted Patent US12605416B2 to PHI THERAPEUTICS, INC. on April 21, 2026, covering therapeutic compositions comprising bacteriophage and colloidal oatmeal for the treatment of skin diseases and conditions including eczema. The patent contains 17 claims classified under CPC A61K 35/76.

Routine Notice Intellectual Property

Get alerts for "PHI THERAPEUTICS, INC."

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

Filters

Browse Categories

Agriculture & Food Safety 73 AI Regulation 3 Banking & Finance 414 Consumer Protection 89 Courts & Legal 411 Data Privacy & Cybersecurity 90 Defense & National Security 53 Education 55 Energy 100 Environment 152 Gaming 2 Government & Legislation 431 Healthcare 15 Healthcare & Life Sciences 375 Immigration 10 Insurance 76 Labor & Employment 138 Pharma & Drug Safety 21 Professional Licensing 8 Real Estate & Housing 78 Securities & Markets 154 Tax 78 Telecom & Technology 47 Trade & Sanctions 141 Transportation 91

Get alerts for "PHI THERAPEUTICS, INC."

We'll email you when new changes match "PHI THERAPEUTICS, INC.".

Free. Unsubscribe anytime.

You're subscribed!